Colgate Palmolive (NYSE:CL)
Historical Stock Chart
3 Months : From Sep 2019 to Dec 2019
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) September 20, 2019 (September 19, 2019)
COLGATE PALMOLIVE COMPANY
(Exact name of registrant as specified in its charter)
Delaware 1-644 13-1815595
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)
300 Park Avenue, New York, New York 10022
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code (212) 310-2000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which
registered
Common Stock, $1.00 par value CL New York Stock Exchange
0.500% Notes due 2026 CL 26 New York Stock Exchange
1.375% Notes due 2034 CL 34 New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01. Other Events.
On September 19, 2019, Colgate-Palmolive Company ("Colgate") completed its previously announced acquisition of Laboratoires Filorga Cosmétiques, pursuant to a Share Purchase Agreement, dated as of July 11, 2019, by and between Colgate and Filorga Initiatives, for a cash purchase price of approximately €1,516 million (approximately US$ 1,674 million), which includes interest on the previously disclosed equity purchase price.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
COLGATE-PALMOLIVE COMPANY
By: /s/ Jennifer M. Daniels
Name: Jennifer M. Daniels
Title: Chief Legal Officer and Secretary
Date: September 20, 2019
(END) Dow Jones Newswires
September 20, 2019 17:32 ET (21:32 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
| 